Role of TNF in mast cell neuroinflammation and pain

Journal of Biological Regulators and Homeostatic Agents

Volumn 29, Issue 4, 2015, Pages 787-791

  Gu, Y ^a   Yang, D K ^a   Spinas, E ^b   Kritas, S K ^c   Saggini, A ^d   Caraffa, A ^e   Antinolfi, P ^e   Saggini, R ^f   Conti, P ^g  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f UNIVERSITY OF CHIETI   (Italy)

^g Post Graduate School of Medicine   (Italy)

Author keywords

Cytokine; Inflammation; Mast cell; TNF

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTE; HEADACHE; HUMAN; MAST CELL; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; PAIN; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; BRAIN DISEASES; INFLAMMATION; PHYSIOLOGY;

BRAIN DISEASES; HUMANS; INFLAMMATION; MAST CELLS; NF-KAPPA B; PAIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84965093155     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Szekanecz Z, Koch AE. Vascular endothelium and immune responses: implications for inflammation and angiogenesis. Rheum Dis Clin North Am 2004; 30(1):97-114. Review.
2. Johnson AC, Greenwood-Van Meerveld B. Stressinduced pain: a target for the development of novel therapeutics. J Pharmacol Exp Ther 2014; 351(2):327-35.
3. Covelli V, Passeri ME, Leogrande D, Jirillo E, Amati L. Drug targets in stress-related disorders. Curr Med Chem 2005; 12(15):1801-9.
4. Gadek-Michalska A, Tadeusz J, Rachwalska P, Bugajski J. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems. Pharmacol Rep 2013; 65(6):1655-62.
5. Schrör K, Rauch BH. Aspirin and lipid mediators in the cardiovascular system. Prostaglandins Other Lipid Mediat 2015; pii: S1098-8823(15)30005-8.
6. Garraway SM, Woller SA, Huie JR, et al. Peripheral noxious stimulation reduces withdrawal threshold to mechanical stimuli after spinal cord injury: role of tumor necrosis factor alpha and apoptosis. Pain 2014; 155(11):2344-59.
7. Myers RR, Shubayev VI. The ology of neuropathy: an integrative review of the role of neuroinflammation and TNF-α axonal transport in neuropathic pain. J Peripher Nerv Syst 2011; 16(4):277-86.
8. Conti P, Pang X, Boucher W, Letourneau R, Reale M, Barbacane RC, Thibault J, Theoharides TC. Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 1997; 89(11):4120-7.
9. Jin Y, Silverman AJ, Vannucci SJ. Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke 2009; 40(9):3107-12.
10. Ibeas E, Fuentes L, Martín R, Hernández M, Nieto ML. Inflammatory protein sPLA(2)-IIA abrogates TNFalpha-induced apoptosis in human astroglioma cells: Crucial role of ERK. Biochim Biophys Acta 2009; 1793(12):1837-47.
11. Anisman H, Merali Z, Hayley S. Sensitization associated with stressors and cytokine treatments. Brain Behav Immun 2003; 17(2):86-93.
12. Perini F, D'Andrea G, Galloni E, Pignatelli F, Billo G, Alba S, Bussone G, Toso V. Plasma cytokine levels in migraineurs and controls. Headache 2005; 45(7):926-31.
13. Zhang B, Weng Z, Sismanopoulos N, et al. Mitochondria distinguish granule-stored from de novo synthesized tumor necrosis factor secretion in human mast cells. Int Arch Allergy Immunol 2012; 159(1):23-32.
14. Toniato E, Spinas E, Saggini A, et al. Immunomodulatory effects of vitamin d on skin inflammation. J Biol Regul Homeost Agents 2015; 29(3):563-7.
15. Spinas E, Kritas SK, Saggini A, et al. Role of mast cells in atherosclerosis: a classical inflammatory disease. Int J Immunopathol Pharmacol 2014; 27(4):517-21.
16. Milovanovic M, Volarevic V, Radosavljevic G, Jovanovic I, Pejnovic N, Arsenijevic N, Lukic ML. IL 33/ST2 axis in inflammation and immunopathology. Immunol Res 2012; 52(1-2):89-99.
17. Spinas E, Saggini A, Kritas SK, et al. Crosstalk between vitamin b and immunity. J Biol Regul Homeost Agents 2015; 29(2):283-88.
18. Karaduman B, Uraz A, Altan GN, Balos Tuncer B, Alkan O, Gonen S, Pehlivan S, Centiner D. Changes of tumor necrosis factor-a, interleukin-10, and tartrate-resistant acid phosphatase5b in the crevicular fluid in relation to orthodontic movement. Eur J Inflamm 2015; 13(1):3-13.
19. Kratochvill F, Neale G, Haverkamp JM, et al. TNF Counterbalances the Emergence of M2 Tumor Macrophages. Cell Rep 2015; 12(11):1902-14.
20. Dinarello CA, van der Meer JW. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol 2013; 25(6):469-84.
21. Sismanopoulos N, Delivanis DA, Mavrommati D, Hatziagelaki E, Conti P, Theoharides TC. Do mast cells link obesity and asthma? Allergy 2013; 68(1):8-15.
22. Stevens SL, Shaw TE, Dykhuizen E, Lessov NS, Hill JK, Wurst W, Stenzel-Poore MP. Reduced cerebral injury in CRH-R1 deficient mice after focal ischemia: a potential link to microglia and atrocytes that express CRH-R1. J Cereb Blood Flow Metab 2003; 23(10):1151-9.